Trials / Completed
CompletedNCT05386706
Treating PCOS With Digital Intervention vs. Metformin
Treating Polycystic Ovarian Syndrome (PCOS) With Digital Intervention vs. Metformin
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Shanghai 10th People's Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
With the change in environment and lifestyle, and the improvement of people's understanding of PCOS, the incidence of PCOS is increasing worldwide. According to statistics, the prevalence of PCOS in premenopausal women is as high as 5-20%. Lifestyle interventions are the main treatment option for patients with PCOS. In addition, research has shown that digital therapy can effectively improve behavior changes in diet, exercise, and medication adherence, predict disease progression, reduce the frequency of disease-related symptoms, and promote effective disease management. This study aimed to investigate the efficacy of digital intervention versus traditional metformin monotherapy in patients with PCOS.
Detailed description
This study developed a mini-program that combined diet, exercise, sleep, and mood interventions for PCOS women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Digital Intervention | This study developed a mini-program that combined diet, exercise, sleep, and mood interventions for PCOS women. |
| DRUG | Metformin | Traditional metformin monotherapy. |
Timeline
- Start date
- 2022-06-21
- Primary completion
- 2023-08-12
- Completion
- 2023-09-01
- First posted
- 2022-05-23
- Last updated
- 2023-11-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05386706. Inclusion in this directory is not an endorsement.